-
公开(公告)号:US08784821B1
公开(公告)日:2014-07-22
申请号:US10554731
申请日:2004-05-26
申请人: Peter Kufer , Tobias Raum , Meera Berry , Roman Kischel , Susanne Mangold , Eva Krinner , Birgit Kohleisen , Steven Zeman , Christian Itin , Patrick Bäuerle
发明人: Peter Kufer , Tobias Raum , Meera Berry , Roman Kischel , Susanne Mangold , Eva Krinner , Birgit Kohleisen , Steven Zeman , Christian Itin , Patrick Bäuerle
IPC分类号: A61K38/00
CPC分类号: C07K16/24 , A61K2039/505 , C07K16/2803 , C07K16/2809 , C07K16/2896 , C07K16/30 , C07K2317/21 , C07K2317/31 , C07K2317/34
摘要: The present invention provides a method for the preparation of a human binding molecule, fragment or derivative thereof which specifically binds to the human CD3 complex. Furthermore, the invention provides a human binding molecules specifically binding to the human CD3 complex and means comprising said human binding molecules.
摘要翻译: 本发明提供了制备与人CD3复合物特异性结合的人结合分子,其片段或衍生物的方法。 此外,本发明提供了特异性结合人CD3复合物的人结合分子和包含所述人结合分子的手段。
-
公开(公告)号:US09102736B2
公开(公告)日:2015-08-11
申请号:US13323206
申请日:2011-12-12
申请人: Robert Hofmeister , Birgit Kohleisen , Ulla Lenkkeri-Schütz , Christian Itin , Patrick Bäuerle , Francis J. Carr , Anita A. Hamilton , Stephen Williams
发明人: Robert Hofmeister , Birgit Kohleisen , Ulla Lenkkeri-Schütz , Christian Itin , Patrick Bäuerle , Francis J. Carr , Anita A. Hamilton , Stephen Williams
CPC分类号: C07K16/2896 , A61K2039/505 , C07K16/2803 , C07K16/2809 , C07K16/30 , C07K2317/24 , C07K2317/31 , C07K2317/567
摘要: The present invention provides a cytotoxically active CD3 specific binding construct comprising a first domain specifically binding to human CD3 and an Ig-derived second binding domain. Furthermore, a nucleic acid sequence encoding a CD3 specific binding construct of the invention is provided. Further aspects of the invention are vectors and host cells comprising said nucleic acid sequence, a process for the production of the construct of the invention and composition comprising said construct. The invention also provides the use of said constructs for the preparation of pharmaceutical compositions for the treatment of particular diseases, a method for the treatment of particular diseases and a kit comprising the binding construct of the invention.
摘要翻译: 本发明提供了细胞毒活性CD3特异性结合构建体,其包含与人CD3特异性结合的第一结构域和来自Ig的第二结合结构域。 此外,提供了编码本发明的CD3特异性结合构建体的核酸序列。 本发明的其它方面是包含所述核酸序列的载体和宿主细胞,用于生产本发明构建体的方法和包含所述构建体的组合物。 本发明还提供所述构建体用于制备用于治疗特定疾病的药物组合物,用于治疗特定疾病的方法和包含本发明的结合构建体的试剂盒的用途。
-
公开(公告)号:US08076459B2
公开(公告)日:2011-12-13
申请号:US10572740
申请日:2004-10-15
申请人: Robert Hofmeister , Birgit Kohleisen , Ulla Lenkkeri-Schütz , Christian Itin , Patrick Bäuerle , Francis J. Carr , Anita A. Hamilton , Stephen Williams
发明人: Robert Hofmeister , Birgit Kohleisen , Ulla Lenkkeri-Schütz , Christian Itin , Patrick Bäuerle , Francis J. Carr , Anita A. Hamilton , Stephen Williams
CPC分类号: C07K16/2896 , A61K2039/505 , C07K16/2803 , C07K16/2809 , C07K16/30 , C07K2317/24 , C07K2317/31 , C07K2317/567
摘要: The present invention provides a cytotoxically active CD3 specific binding construct comprising a first domain specifically binding to human CD3 and an IG-derived second binding domain. Furthermore, a nucleic acid sequence encoding a CD3 specific binding construct is provided. Further aspects of the invention are vectors and host cells comprising the nucleic acid sequences, a process for the production of the construct and composition comprising the construct. The invention also provides the use of the constructs for the preparation of pharmaceutical compositions for the treatment of particular diseases, a method for the treatment of particular diseases and a kit comprising the binding construct of the invention.
摘要翻译: 本发明提供细胞毒活性的CD3特异性结合构建体,其包含与人CD3特异性结合的第一结构域和来自IG的第二结合结构域。 此外,提供编码CD3特异性结合构建体的核酸序列。 本发明的其它方面是包含核酸序列的载体和宿主细胞,用于生产构建体的方法和包含该构建体的组合物。 本发明还提供了用于制备用于治疗特定疾病的药物组合物的构建体的用途,用于治疗特定疾病的方法和包含本发明的结合构建体的试剂盒。
-
公开(公告)号:US20130224205A1
公开(公告)日:2013-08-29
申请号:US13323206
申请日:2011-12-12
申请人: Robert HOFMEISTER , Birgit Kohleisen , Ulla Lenkkeri-Schütz , Christian Itin , Patrick Bäuerle , Francis J. Carr , Anita A. Hamilton , Stephen Williams
发明人: Robert HOFMEISTER , Birgit Kohleisen , Ulla Lenkkeri-Schütz , Christian Itin , Patrick Bäuerle , Francis J. Carr , Anita A. Hamilton , Stephen Williams
IPC分类号: C07K16/28
CPC分类号: C07K16/2896 , A61K2039/505 , C07K16/2803 , C07K16/2809 , C07K16/30 , C07K2317/24 , C07K2317/31 , C07K2317/567
摘要: The present invention provides a cytotoxically active CD3 specific binding construct comprising a first domain specifically binding to human CD3 and an Ig-derived second binding domain. Furthermore, a nucleic acid sequence encoding a CD3 specific binding construct of the invention is provided. Further aspects of the invention are vectors and host cells comprising said nucleic acid sequence, a process for the production of the construct of the invention and composition comprising said construct. The invention also provides the use of said constructs for the preparation of pharmaceutical compositions for the treatment of particular diseases, a method for the treatment of particular diseases and a kit comprising the binding construct of the invention.
摘要翻译: 本发明提供了细胞毒活性的CD3特异性结合构建体,其包含与人CD3特异性结合的第一结构域和来自Ig的第二结合结构域。 此外,提供了编码本发明的CD3特异性结合构建体的核酸序列。 本发明的其它方面是包含所述核酸序列的载体和宿主细胞,用于生产本发明构建体的方法和包含所述构建体的组合物。 本发明还提供所述构建体用于制备用于治疗特定疾病的药物组合物,用于治疗特定疾病的方法和包含本发明的结合构建体的试剂盒的用途。
-
公开(公告)号:US20050136050A1
公开(公告)日:2005-06-23
申请号:US10743697
申请日:2003-12-22
申请人: Peter Kufer , Meera Berry , Patrick Baeuerle , Christian Itin
发明人: Peter Kufer , Meera Berry , Patrick Baeuerle , Christian Itin
IPC分类号: C07K14/705 , C07K16/28 , C07K16/30 , C07K16/46 , C12N15/85 , A61K39/395 , C07K16/44
CPC分类号: C07K16/30 , C07K14/70567 , C07K16/2809 , C07K2317/31 , C07K2317/569 , C07K2317/622 , C07K2319/00 , C07K2319/21 , C07K2319/33 , C12N15/8509 , C12N2830/008 , C12N2830/48
摘要: The present invention discloses bispecific antibodies comprising two antibody variable domains on a single polypeptide chain, wherein a first portion of the bispecific antibody is capable of recruiting the activity of a human immune effector cell by specifically binding to an effector antigen on the human immune effector cell, the first portion consisting of one antibody variable domain, and a second portion of the bispecific antibody specifically binding to a target antigen other than the effector antigen, the target antigen on a target cell other than the human immune effector cell, the second portion comprising one antibody variable domain.
摘要翻译: 本发明公开了在单个多肽链上包含两个抗体可变结构域的双特异性抗体,其中双特异性抗体的第一部分能够通过特异性结合人免疫效应细胞上的效应物抗原募集人免疫效应细胞的活性 ,第一部分由一个抗体可变结构域组成,第二部分特异性结合除效应物抗原之外的靶抗原的双特异性抗体,除人免疫效应细胞以外的靶细胞上的靶抗原,第二部分包含 一个抗体可变结构域。
-
公开(公告)号:US20080305105A1
公开(公告)日:2008-12-11
申请号:US11754792
申请日:2007-05-29
申请人: Peter Kufer , Meera Berry , Patrick Baeuerle , Christian Itin
发明人: Peter Kufer , Meera Berry , Patrick Baeuerle , Christian Itin
IPC分类号: A61K39/395 , C07K16/18 , A61P31/00
摘要: The present invention discloses bispecific antibodies comprising two antibody variable domains on a single polypeptide chain, wherein a first portion of the bispecific antibody is capable of recruiting the activity of a human immune effector cell by specifically binding to an effector antigen on the human immune effector cell, the first portion consisting of one antibody variable domain, and a second portion of the bispecific antibody specifically binding to a target antigen other than the effector antigen, the target antigen on a target cell other than the human immune effector cell, the second portion comprising one antibody variable domain.
摘要翻译: 本发明公开了在单个多肽链上包含两个抗体可变结构域的双特异性抗体,其中双特异性抗体的第一部分能够通过特异性结合人免疫效应细胞上的效应物抗原募集人免疫效应细胞的活性 ,第一部分由一个抗体可变结构域组成,第二部分特异性结合除效应物抗原之外的靶抗原的双特异性抗体,除人免疫效应细胞以外的靶细胞上的靶抗原,第二部分包含 一个抗体可变结构域。
-
公开(公告)号:US07235641B2
公开(公告)日:2007-06-26
申请号:US10743697
申请日:2003-12-22
申请人: Peter Kufer , Meera Berry , Patrick Baeuerle , Christian Itin
发明人: Peter Kufer , Meera Berry , Patrick Baeuerle , Christian Itin
CPC分类号: C07K16/30 , C07K14/70567 , C07K16/2809 , C07K2317/31 , C07K2317/569 , C07K2317/622 , C07K2319/00 , C07K2319/21 , C07K2319/33 , C12N15/8509 , C12N2830/008 , C12N2830/48
摘要: The present invention discloses bispecific antibodies comprising two antibody variable domains on a single polypeptide chain, wherein a first portion of the bispecific antibody is capable of recruiting the activity of a human immune effector cell by specifically binding to an effector antigen on the human immune effector cell, the first portion consisting of one antibody variable domain, and a second portion of the bispecific antibody specifically binding to a target antigen other than the effector antigen, the target antigen on a target cell other than the human immune effector cell, the second portion comprising one antibody variable domain.
摘要翻译: 本发明公开了在单个多肽链上包含两个抗体可变结构域的双特异性抗体,其中双特异性抗体的第一部分能够通过特异性结合人免疫效应细胞上的效应物抗原募集人免疫效应细胞的活性 ,第一部分由一个抗体可变结构域组成,第二部分特异性结合除效应物抗原之外的靶抗原的双特异性抗体,除人免疫效应细胞以外的靶细胞上的靶抗原,第二部分包含 一个抗体可变结构域。
-
公开(公告)号:US20090022738A1
公开(公告)日:2009-01-22
申请号:US10572740
申请日:2004-10-15
申请人: Robert Hofmeister , Birgit Kohleisen , Ulla Lenkkeri-Schutz , Christian Itin , Patrick Bauerle , Francis J. Carr , Anita A. Hamilton , Stephen Williams
发明人: Robert Hofmeister , Birgit Kohleisen , Ulla Lenkkeri-Schutz , Christian Itin , Patrick Bauerle , Francis J. Carr , Anita A. Hamilton , Stephen Williams
IPC分类号: A61K39/395 , C07K16/00 , C07H21/00 , C12N15/63 , A61K35/12 , A61P39/00 , A61P37/02 , A61P35/00 , A61K31/7052 , C12N5/00 , C12P21/00
CPC分类号: C07K16/2896 , A61K2039/505 , C07K16/2803 , C07K16/2809 , C07K16/30 , C07K2317/24 , C07K2317/31 , C07K2317/567
摘要: The present invention provides a cytotoxically active CD3 specific binding construct comprising a first domain specifically binding to human CD3 and an Ig-derived second binding domain. Furthermore, a nucleic acid sequence encoding a CD3 specific binding construct of the invention is provided. Further aspects of the invention are vectors and host cells comprising said nucleic acid sequence, a process for the production of the construct of the invention and composition comprising said construct. The invention also provides the use of said constructs for the preparation of pharmacutical compositions for the treatment of particular diseases, a method for the treatment of particular diseases and a kit comprising the binding construct of the invention.
摘要翻译: 本发明提供了细胞毒活性CD3特异性结合构建体,其包含与人CD3特异性结合的第一结构域和来自Ig的第二结合结构域。 此外,提供了编码本发明的CD3特异性结合构建体的核酸序列。 本发明的其它方面是包含所述核酸序列的载体和宿主细胞,用于生产本发明构建体的方法和包含所述构建体的组合物。 本发明还提供所述构建体用于制备用于治疗特定疾病的药物组合物,用于治疗特定疾病的方法和包含本发明的结合构建体的试剂盒的用途。
-
公开(公告)号:US20050176028A1
公开(公告)日:2005-08-11
申请号:US10966406
申请日:2004-10-15
申请人: Robert Hofmeister , Christian Itin , Francis Carr , Patrick Bauerle , Anita Hamilton , Stephen Williams
发明人: Robert Hofmeister , Christian Itin , Francis Carr , Patrick Bauerle , Anita Hamilton , Stephen Williams
CPC分类号: C07K16/461 , A61K2039/505 , C07K16/2809 , C07K2317/24 , C07K2317/622
摘要: The invention provides CD3 specific binding molecules and nucleic acid sequences encoding said CD3 specific binding molecules. Further aspects of the invention are vectors and host cells comprising said nucleic acid sequence, a process for the production of the construct of the invention and compositions comprising said construct. The invention also provides the use of said constructs for the preparation of pharmacutical compositions for the treatment of particular diseases, a method for the treatment of particular diseases and a kit comprising the binding construct of the invention.
摘要翻译: 本发明提供CD3特异性结合分子和编码所述CD3特异性结合分子的核酸序列。 本发明的其它方面是包含所述核酸序列的载体和宿主细胞,用于生产本发明构建体的方法和包含所述构建体的组合物。 本发明还提供所述构建体用于制备用于治疗特定疾病的药物组合物,用于治疗特定疾病的方法和包含本发明的结合构建体的试剂盒的用途。
-
公开(公告)号:US06780582B1
公开(公告)日:2004-08-24
申请号:US09574692
申请日:2000-05-17
申请人: Peter Wagner , Steffen Nock , Dana Ault-Riche , Christian Itin
发明人: Peter Wagner , Steffen Nock , Dana Ault-Riche , Christian Itin
IPC分类号: G01N33543
CPC分类号: B82Y5/00 , B01J2219/00605 , B01J2219/0061 , B01J2219/00612 , B01J2219/00617 , B01J2219/00619 , B01J2219/00621 , B01J2219/00626 , B01J2219/00635 , B01J2219/00637 , B01J2219/00644 , B01J2219/00659 , B01J2219/00702 , B01J2219/00725 , B82Y30/00 , C40B40/10 , G01N33/54393 , G01N33/551
摘要: Arrays of protein-capture agents useful for the simultaneous detection of a plurality of proteins which are the expression products, or fragments thereof, of a cell or population of cells in an organism are provided. A variety of antibody arrays, in particular, are described. Methods of both making and using the arrays of protein-capture agents are also disclosed. The invention arrays are particularly useful for various proteomics applications including assessing patterns of protein expression and modification in cells.
摘要翻译: 提供了可用于同时检测生物体中细胞或细胞群的表达产物或其片段的多种蛋白质的蛋白质捕获剂的阵列。 特别描述了各种抗体阵列。 还公开了制备和使用蛋白质捕获剂的阵列的方法。 本发明阵列对于各种蛋白质组学应用特别有用,包括评估细胞中蛋白质表达和修饰的模式。
-
-
-
-
-
-
-
-
-